Last reviewed · How we verify
NCT04607798
Multi-polar RF and PEMF for Treatment of Vulvovaginal Atrophy
NA trial testing Radiofrequency and pulsed electro-magnetic fields treatment in Genitourinary Syndrome of Menopause in 40 participants. Completed in 31 May 2020.
31 May 2020
Quick facts
| Lead sponsor | Venus Concept |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 3 October 2017 |
| Primary completion | 31 May 2020 |
| Estimated completion | 31 May 2020 |
| Sites | 1 location across Ukraine |
Drugs / interventions tested
- Radiofrequency and pulsed electro-magnetic fields treatment
Conditions studied
- Genitourinary Syndrome of Menopause — all drugs for Genitourinary Syndrome of Menopause →
- Vulvovaginal Atrophy — all drugs for Vulvovaginal Atrophy →
- Menopause — all drugs for Menopause →
Sponsor
Venus Concept
Who can join
19 and older, female only, with Genitourinary Syndrome of Menopause or Vulvovaginal Atrophy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study evaluates the use of multi-polar radiofrequency (RF) and pulsed electro-magnetic fields (PEMF) energies for the treatment of symptoms related to genitourinary syndrome of menopause (GSM)/vulvovaginal atrophy (VVA). All subjects will receive a total of three internal treatments at four week intervals. Subjects will be followed up at one and four months after treatment is complete.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04607798
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Genitourinary Syndrome of Menopause
Currently open trials in the same condition.
- NCT06873971 — Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause · NA · recruiting
- NCT06007027 — Vaginal CO2 Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors · NA · recruiting
- NCT06508788 — Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndro · recruiting
- NCT06925139 — Efficacy of Non-Ablative Radiofrequency on Vaginal and Sexual Health in Postmenopausal Women · NA · active not recruiting
- NCT06028009 — PRP Injections for Genitourinary Syndrome of Menopause · NA · active not recruiting
Other Venus Concept trials
Trials by the same sponsor.
- NCT05897723 — Fractional Radiofrequency for Reduction of Surgical Scar Formation · NA · unknown
- NCT05091788 — Robotic Mechanical Coring for the Treatment of Moderate to Severe Facial Wrinkles · NA · unknown
- NCT05256771 — Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction. · NA · active not recruiting
- NCT04827680 — Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring · NA · completed
- NCT04910945 — Mechanical Coring to Achieve Directional Skin Tightening · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04607798 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Venus Concept
- Last refreshed: 29 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04607798.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing